ONTOFORCE, developer of life sciences data management applications, appointed Valerie Morel as new CEO in April 2021.
Valerie Morel has a keen interest in life sciences and a track record of growing global technology companies. Her interest and experience lies in management and board experience in life sciences, financial services, data & technology. In 1991, she graduated as a Commercial Engineer (KUL). As an experienced executive, she will lead ONTOFORCE through its next growth phase.
The Company has built a great product and is now ready for the next phase: accelerate growth and scale up globally.
Valerie Morel will join forces with Hans Cobben, with whom she previously worked at BlueBee, the Netherlands-based genomics cloud data developer which was recently acquired by Illumina.
Valerie Morel is ready to achieve great things together with the team and guide the Company towards global expansion.
“The emphasis is really on the added value that we can provide for the manufacturers of medicines, for example. We are not a toolbox, we are not a platform, but we offer concrete solutions for scientists.”
– Valerie Morel
For more information: Ontoforce , +32 09 292 80 37
Read the press release
About ONTOFORCE
For more than a decade, ONTOFORCE has addressed the problem that many life sciences companies struggle with, when bringing together structured and unstructured data to create new insights. These insights lead to accelerated drug discovery, more in-depth insights into research, real-world evidence, optimized clinical trial research, and a faster go-to-market.
ONTOFORCE already works for lighthouse customers such as Amgen, UCB,BMS, Roche, Medidata, and numerous other life sciences colleagues. Thanks to the intense collaboration with renowned research institutes such as IMEC, VIB, UGent, KULeuven, and international research and industrial consortia such as ELIXIR, FAIRplus, and Pistoia Alliance, it guarantees that you are engaging with a global player that has made transforming data into insights its primary objective.